Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Übersichtsarbeiten / Review Articles

Atypische Neuroleptika in der Kinder- und Jugendpsychiatrie

Published Online:September 01, 2006https://doi.org/10.1024//1422-4917.28.1.45

Abstract

Zusammenfassung: Atypische Neuroleptika haben unsere Therapiemöglichkeiten in der Kinder- und Jugendpsychiatrie verbessert. Dieser Artikel faßt die Anwendung der atypischen Neuroleptika bei Kindern und Jugendlichen mit schizophrenen Psychosen zusammen. Es werden das Rezeptor-Bindungsprofil, pharmakologische Eigenschaften, Indikationen, Nebenwirkungen, klinische Anwendungen und Studien der atypischen Neuroleptika, im Vergleich zu dem klassischen Neuroleptikum Haloperidol, berücksichtigt. Besondere Betonung wurde auf die am häufigsten verwendeten atypischen Neuroleptika Clozapin, Olanzapin und Risperidon gelegt, da weltweit die meisten Studien mit diesen Medikamenten durchgeführt worden sind. Der Stellenwert der atypischen Neuroleptika wird diskutiert und es werden weitere Studien gefordert, um die Indikationen zu differenzieren, und um zu sehen, ob das Indikationsspektrum erweitert werden kann.


Summary:The use of atypical neuroleptic drugs in Child and Adolescent Psychiatry.

Atypical neuroleptic drugs have enriched our treatment programs, especially in childhood and adolescent schizophrenia. Reviewed here is the use of atypical neuroleptics in children and adolescents with a schizophrenic disorder. The receptor binding profile and pharmacological properties, indications, side effects, clinical application, and trials of atypical neuroleptic drugs are compared to the classical neuroleptic drug haloperidol in the treatment of adolescent schizophrenia. Special attention is paid to the most common atypical neuroleptics clozapine, olanzapine and risperidone since most studies are carried out with these compounds, most often with clozapine. More clinically controlled trials have to be conducted since only one has been performed to date. The place of atypical neuroleptic drugs is discussed and further studies are necessary in order to differentiate, and eventually broaden the spectrum of the indications tested thus far.

Literatur

  • Abczynska, M. , Kazmirek, Z. , Syguda, J. , Terminska, K. Own experience (1989-1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz Company.. Psychiatria Polska, 29, 79– 85 (1995). First citation in articleMedline, Google Scholar

  • Aravagiri, M. , Marder, S.R. , Wirshing, D. , Wirshing, W.C. Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection.. Pharmacopsychiatry, 31, 102– l09 (1998). First citation in articleCrossref Medline, Google Scholar

  • Armenteros, J.L. , Whitaker, A.H. , Welikson, M. , Stedge, D.J. , Gorman, J. Risperidone in adolescents with schizophrenia: an open pilot study.. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 694– 700 (1997). First citation in articleCrossref Medline, Google Scholar

  • Beasley, C.M. , Tollefson, G.D. , Tran, P. , Satterlee, W. , Sanger, T. , Holman, S. The Olanzapine HGAD Study Group: Olanzapine versus placebo and haloperidol; acute phase results of the North American double blind olanzapine trial.. Neuropsychopharmacology, 14, 111– 123 (1996). First citation in articleCrossref Medline, Google Scholar

  • Blanz, B. , Schmidt, M.H. Clozapine for schizophrenia ‘letter; comment’.. Journal of the American Academy of Child & Adolescent Psychiatry, 32, 223– 224 (1993). First citation in articleCrossref Medline, Google Scholar

  • Bleeham, T. Leponex® - Clozaril® (clozapine) - literature review.. Sandoz Pharma Ltd, Basel, Switzerland (1993). First citation in articleGoogle Scholar

  • Bondolfi, G. , Dufour, H. , Patris, M. , May, J.P. , Billeter, U. , Eap, C.B. , Baumann, P. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized doubleblind study. The Risperidone Study Group.. American Journal of Psychiatry, 155, 499– 504 (1998). First citation in articleCrossref Medline, Google Scholar

  • Cardoni, A.A. Risperidone: Review and assessment of its role in the treatment of schizophrenia.. Annals of Pharmacotherapy, 29, 610– 618 (1995). First citation in articleMedline, Google Scholar

  • Carman, J. , Peuskens, J. , Vangeneugden, A. Risperidone in the treatment of negative symptoms of schizophrenia: a metaanalysis.. International Clinical Psychopharmacology, 10, 207– 213 (1995). First citation in articleCrossref Medline, Google Scholar

  • Casey, D.E. Clozapine; Neuroleptic-induced ES and tardive dyskinesia.. Psychopharmacology, 99, 47– 53 (1989). First citation in articleCrossref, Google Scholar

  • Catlow, J.T. , Barton, R.D. , Clemens, M. , Gillespie, T.A. , Goodwin, M. , Swanson, S.P. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection.. Journal of Chromatography: Biomedical Applications, 668, 85– 90 (1995). First citation in articleCrossref Medline, Google Scholar

  • Clement, H.W. , Fleischhaker, C. , Sudhop, B. , Schulz, E. , Remschmidt, H. HPLC-determination of olanzapine in serum samples of schizophrenic patients.. Biological Chemistry, 379SS, 39– 39 (1998). First citation in articleGoogle Scholar

  • Coward, D.M. General pharmacology of clozapine.. British Journal of Psychiatry, 160 (Suppl. 17), 5– 11 (1992). First citation in articleGoogle Scholar

  • Degner, D. , Rüther, E. “Atypische” Neuroleptika in der Schizophreniebehandlung.. Nervenheilkunde, 17, 472– 479 (1998). First citation in articleGoogle Scholar

  • Ekblom, B. , Haggstrom, J.E. Clozapine (Leponex) compared with chlorpromazine: A double-blind evaluation of pharmacological and clinical properties.. Current Therapy Research, 16, 945– 957 (1974). First citation in articleMedline, Google Scholar

  • Elliger, T. , Englert, E. , Freisleder, F.J. , Friedrich, M. , Gierow, B. , Holstein, K. , Linder, M. , Remschmidt, H. , Resch, F. , Schmidt, M.H. , Schulz, E. , Trott, G.E. , Warnke, A. Zur Behandlung schizophrener Psychosen des Kindes- und Jugendalters mit Clozapin (Leponex). Konsensus-Konferenz vom 4. März 1994.. Zeitschrift für Kinder- und Jugendpsychiatrie, 22, 325– 327 (1994). First citation in articleGoogle Scholar

  • Farde, L. , Nordstrom, A.L. , Nyberg, S. , Halldin, C. , Sedvall, G. D1-, D2- and 5-HT2-receptor occupancy in clozapine-treated patients.. Journal of Clinical Psychiatry, 55 (Suppl. B), 67– 69 (1994). First citation in articleMedline, Google Scholar

  • Farde, L. , Nyberg, S. , Oxenstierna, G. , Nakashima, Y. , Halldin, C. , Ericsson, B. Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.. Journal of Clinical Psychopharmacology, 15 (Suppl. 1), S19– 23 (1995). First citation in articleGoogle Scholar

  • Flynn, S.W. , MacEwan, G.W. , Altman, S. , Kopala, L.C. , Fredrikson, D.H. , Smith, G.N. , Honer, W.G. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.. Pharmacopsychiatry, 31, 25– 29 (1998). First citation in articleCrossref Medline, Google Scholar

  • Frazier, J.A. , Gordon, C.T. , McKenna, K. , Lenane, M.C. , Jih, D. , Rapoport, J.L. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia.. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 658– 663 (1994). First citation in articleCrossref Medline, Google Scholar

  • Gardner, D.M. Olanzapine.. Child and Adolescent Psychopharmacology News, 2, 1– 5 (1997). First citation in articleGoogle Scholar

  • Gordon, C.T. , Frazier, J.A. , McKenna, K. , Giedd, J. , Zametkin, A. , Zahn, T. , Hommer, D. , Hong, W. , Kaysen, D. , Albus, K.E. Childhood-onset schizophrenia: an NIMH study in progress.. Schizophrenia Bulletin, 20, 697– 712 (1994). First citation in articleCrossref Medline, Google Scholar

  • Kapur, S. , Zipursky, R. , Remington, G. , Jones, C. , McKay, G. , Houle, S. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.. American Journal of Psychiatry, 154, 1525– 1529 (1997). First citation in articleCrossref Medline, Google Scholar

  • Kimmel, S.E. , Calabrese, J.R. , Woyshville, M.J. , Meltzer, H.Y. Clozapine in treatment-refractory mood disorders.. Journal of Clinical Psychiatry, 55 (Suppl. B), 91– 93 (1994). First citation in articleMedline, Google Scholar

  • Kornhuber, J. , Weller, M. Aktueller Stand der biochemischen Hypothesen zur Pathogenese der Schizophrenie.. Nervenarzt, 65, 741– 754 (1994). First citation in articleMedline, Google Scholar

  • Kumra, S. , Frazier, J.A. , Jacobsen, L.K. , McKenna, K. , Gordon, C.T. , Lenane, M.C. , Hamburger, S.D. , Smith, A.K. , Albus, K.E. , Alaghband-Rad, J. , Rapoport, J.L. Childhoodonset schizophrenia. A double-blind clozapine-haloperidol comparison.. Archives of General Psychiatry, 53 (12), 1090– 1097 (1996). First citation in articleCrossref, Google Scholar

  • Kumra, S. , Jacobsen, L.K. , Lenane, M.C. , Karp, B.I. , Frazier, J.A. , Smith, A.K. , Bedwell, J. , Lee, P. , Malanga, C.J. , Hamburger, S.D. , Rapoport, J.L. Childhood-onset schizophrenia: an openlabel study of olanzapine in adolescents.. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 377– 385 (1998). First citation in articleCrossref Medline, Google Scholar

  • Levkovitch, Y. , Kaysar, N. , Kronnenberg, Y. , Hagai, H. , Gaoni, B. Clozapine for schizophrenia ‘letter’.. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 431– 431 (1994). First citation in articleCrossref Medline, Google Scholar

  • Lykes, W.C. , Cueva, J.E. Risperidone in children with schizophrenia.. Journal of the American Academy of Child and Adolescent Psychiatry, 35 (4), 405– 406 (1996). First citation in articleCrossref, Google Scholar

  • Mandoki, M. Anti-aggressive effects of clozapine in children and adolescents ‘abstract’. Proceedings of the Annual Meeting, Society for Biological Psychiatry, Philadelphia.. Biological Psychiatry, 35 (Suppl.), 469– 469 (1994). First citation in articleGoogle Scholar

  • Marder, S.R. , Maibach, R.C. Risperidone in the treatment of schizophrenia.. American Journal of Psychiatry, 154, 825– 835 (1994). First citation in articleGoogle Scholar

  • Mattiuz, E. , Franklin, R. , Gillespie, T. , Murphy, A. , Bernstein, J. , Chiu, A. , Hotten, T. , Kassahun, K. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.. Drug Metabolism and Disposition, 25, 573– 583 (1997). First citation in articleMedline, Google Scholar

  • Meltzer, H.Y. Role of serotonin in the action of atypical antipsychotic drugs.. Clinical Neuroscience, 3, 64– 75 (1995). First citation in articleMedline, Google Scholar

  • Mijnster, M.J. , Schotte, A. , Docter, G.J. , Voorn, P. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.. Synapse, 28, 302– 312 (1998). First citation in articleCrossref Medline, Google Scholar

  • Olesen, O.V. Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations.. Clinical Pharmacokinetics, 34, 497– 502 (1998). First citation in articleCrossref Medline, Google Scholar

  • Olesen, O.V. , Licht, R.W. , Thomsen, E. , Bruun, T. , Viftrup, J.E. , Linnet, K. Serum concentrations and side effects in psychiatric patients during risperidone therapy.. Therapeutic Drug Monitoring, 20, 380– 384 (1998). First citation in articleCrossref Medline, Google Scholar

  • Piscitelli, S.C. , Frazier, J.A. , McKenna, K. , Albus, K.E. , Grothe, D.R. , Gordon, C.T. , Rapoport, J.L. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.. Journal of Clinical Psychiatry, 55 (9 Suppl. B, 94– 97 (1994). First citation in articleGoogle Scholar

  • Remington, G. Selecting a neuroleptic and the role of side effects.. Child and Adolescent Psychopharmacology News, 2, 1– 5 (1997). First citation in articleGoogle Scholar

  • Remschmidt, H. Schizophrenic psychoses in children and adolescents. Triangle, 32, 15– 24 (1993). First citation in articleGoogle Scholar

  • Remschmidt, H. , Schulz, E. , Martin, M. An open trial of clozapine in thirtysix adolescents with schizophrenia.. Journal of Child and Adolescent Psychopharmacology, 4, 31– 41 (1994a). First citation in articleCrossref, Google Scholar

  • Remschmidt, H. , Schulz, E. , Martin, M. , Warnke, A. , Trott, G.E. Childhood-onset schizophrenia: History of the concept and recent studies.. Schizophrenia Bulletin, 20, 727– 745 (1994b). First citation in articleCrossref Medline, Google Scholar

  • Remschmidt, H. , Martin, M. , Hennighausen, K. , Schulz, E. Treatment, rehabilitation and prevention.. In: Remschmidt, H. (Hrsg): Schizophrenia in children and adolescents. Developmental and clinical perspectives. Cambridge University Press, Cambridge: eingereicht (1999). First citation in articleGoogle Scholar

  • Roth, B.L. , Craigo, S.C. , Choudhary, M.S. , Uluer, A. , Monsma, F.J.Jr. , Shen, Y. , Meltzer, H.Y. , Sibley, D.R. Binding of typical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.. Journal of Pharmacology and Experimental Therapeutics, 268, 1403– 1410 (1994). First citation in articleMedline, Google Scholar

  • Sanyal, S. , Van Tol, H.H. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.. Journal of Psychiatric Research, 31, 219– 232 (1997). First citation in articleCrossref Medline, Google Scholar

  • Schmidt, M.H. , Trott, G.E. , Blanz, B. Clozapine medication in adolescents.. In: Stefanis, C.N.; Rabavilas, A.D.; Soldatos, C.R. (Hrsg.); Psychiatry: A World Perspective, Vol. 1. Proceedings of the 8th World Congress of Psychiatry, Athens, Greece, October 12-19, Amsterdam: Excerpta Medica 1100-1104 (1989). First citation in articleGoogle Scholar

  • Schulz, E. , Fleischhaker, C. , Remschmidt, H. Determination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high performance liquid chromatography. Data from a prospective clinical trial.. Pharmacopsychiatry, 28, 20– 25 (1995). First citation in articleCrossref Medline, Google Scholar

  • Schulz, E. , Fleischhaker, C. , Remschmidt, H. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adulthood schizophrenia.. Journal of Child and Adolescent Psychopharmacology, 6, 119– 131 (1996). First citation in articleCrossref Medline, Google Scholar

  • Schulz, E. , Fleischhaker, C. , Clement, H.W. , Remschmidt, H. Blood biogenic amines during clozapine treatment of earlyonset schizophrenia.. Journal of Neural Transmission, 104, 1077– 1089 (1997). First citation in articleCrossref Medline, Google Scholar

  • Sedvall, G. , Pauli, S. , Farde, L. , Karlsson, P. , Nyberg, S. , Nordstrom, A.L. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.. Israel Journal of Psychiatry and Related Sciences, 32, 22– 29 (1995). First citation in articleMedline, Google Scholar

  • Siefen, G. , Remschmidt, H. Results of treatment with clozapine in schizophrenic adolescents.. Zeitschrift für Kinder- und Jugendpsychiatrie, 14, 245– 247 (1986). First citation in articleMedline, Google Scholar

  • Suppes, T. , McElroy, S.L. , Gilber, J. , Dessain, E.C. , Cole, J.O. Clozapine in the treatment of dysphoric mania.. Biological Psychiatry, 32, 270– 280 (1992). First citation in articleCrossref Medline, Google Scholar

  • Stockton, M.E. , Rasmussen, K. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.. Neuropsychopharmacology, 14, 92– 104 (1996). First citation in articleCrossref, Google Scholar

  • Toren, P. , Laor, N. , Weizman, A. Use of atypical neuroleptics in child and adolescent psychiatry.. Journal of Clinical Psychiatry, 59, 644– 656 (1998). First citation in articleCrossref Medline, Google Scholar

  • Turetz, M. , Mozes, T. , Toren, P. , Chernauzan, N. , Yoran-Hegesh, R. , Mester, R. , Wittenberg, N. , Tyano, S. , Weizman, A. An open trial of clozapine in neuroleptic-resistant childhoodonset schizophrenia.. British Journal of Psychiatry, 170, 507– 510 (1997). First citation in articleCrossref Medline, Google Scholar

  • Van Rossum, J.M. The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs.. Archives of International Pharmacodynamic Therapy, 160, 492– 494 (1966). First citation in articleMedline, Google Scholar

  • Zhang, G.O. , McKay, G. , Hubbard, J.W. , Midha, K.K. Application of electrospray mass spectrometry in the identification of intact glucoronide and sulphate conjugates of clozapine in rat.. Xenobiotica, 26, 541– 550 (1996). First citation in articleCrossref Medline, Google Scholar